AstraZeneca and the European Union have reached an agreement to end their legal battle AstraZeneca and the European Union have reached an agreement to end their legal battle AstraZeneca has agreed to provide 60 million vaccine doses by the end of the third quarter of 2021, 75 million by the end of the fourth quarter of 2021, and 65 million by the end of the first quarter of 2022 under the terms of the agreement.